Cargando…

The efficacy and safety of tacrolimus on top of glucocorticoids in the management of IIM-ILD: A retrospective and prospective study

OBJECTIVE: To examine the efficacy of tacrolimus on top of glucocorticoids (GCs) in the management of idiopathic inflammatory myopathies-associated interstitial lung disease (IIM-ILD) and further assess the therapeutic benefit and safety of low-dose pirfenidone followed above treatments. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yuxue, Bai, Zhiqian, Zhang, Ziyun, Hu, Qiongjie, Zhong, Jixin, Dong, Lingli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479328/ https://www.ncbi.nlm.nih.gov/pubmed/36119045 http://dx.doi.org/10.3389/fimmu.2022.978429

Ejemplares similares

Amphiphysin IIm Is Required for Survival of Chlamydia pneumoniae in Macrophages
por: Gold, Elizabeth S., et al.
Publicado: (2004)

Club Cell Loss as a Feature of Bronchiolization in ILD
por: Reynaud, Paul, et al.
Publicado: (2021)

SUN-715 IIM May Influence Matured Oocytes’ DNA Methylation of PCOS Patients
por: Li, Congru, et al.
Publicado: (2020)

Temporomandibular Disorders and Oral Features in Idiopathic Inflammatory Myopathies (IIMs) Patients: An Observational Study
por: Crincoli, Vito, et al.
Publicado: (2021)

Analysis of the safety and efficacy of tacrolimus combined with glucocorticoid in the treatment of lupus nephritis
por: Li, Lu, et al.
Publicado: (2022)

Interstitial lung disease (ILD) in India: Insights and lessons from the prospective, landmark ILD-India registry
por: Raghu, Ganesh, et al.
Publicado: (2016)

Cytokine signaling converging on IL11 in ILD fibroblasts provokes aberrant epithelial differentiation signatures
por: Kastlmeier, Miriam T., et al.
Publicado: (2023)

Potential roles of non-lymphocytic cells in the pathogenesis of IgG4-related disease
por: Cai, Shaozhe, et al.
Publicado: (2022)

The PH‐ILD Detection tool: External validation and use in patients with ILD
por: Parikh, Raj, et al.
Publicado: (2023)

Tracking Validation of ILD
por: Lu, S.
Publicado: (2018)

ILD simulation model
por: Lu, S.
Publicado: (2018)

Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality
por: Tsitoura, Eliza, et al.
Publicado: (2021)

Efficacy and safety of tacrolimus combined with glucocorticoid treatment for IgA nephropathy: a meta-analysis
por: Zhang, Yong, et al.
Publicado: (2018)

Crystal structure and mechanism of action of the N6-methyladenine-dependent type IIM restriction endonuclease R.DpnI
por: Siwek, Wojciech, et al.
Publicado: (2012)

Report on Abstracts of the 15th Meeting of IIM, the Interuniversity Institute of Myology - Assisi (Italy), October 11-14, 2018
por: Gabellini, Davide, et al.
Publicado: (2018)

Report and Abstracts of the 17th Meeting of IIM, the Interuniversity Institute of Myology:Virtual meeting, October 16-18, 2020
por: Sorci, Guglielmo, et al.
Publicado: (2021)

Proteomic characteristics of saliva in patients with different subgroups of IgG4-RD
por: Lin, Sheng-Yan, et al.
Publicado: (2022)

The design of the ILD forward region
por: Levy, A
Publicado: (2018)

(Selected) MDI Issues of ILD
por: Pöschl, Roman
Publicado: (2020)

ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF
por: Durheim, Michael T, et al.
Publicado: (2020)

16th Meeting of the Interuniversity Institute of Myology (IIM) - Assisi (Italy), October 17-20, 2019: Foreword, Program and Abstracts
por: Gabellini, Davide, et al.
Publicado: (2020)

Glucocorticoids and Glucocorticoid-Induced-Leucine-Zipper (GILZ) in Psoriasis
por: Sevilla, Lisa M., et al.
Publicado: (2019)

Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease
por: Huang, Jie, et al.
Publicado: (2022)

Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)
por: Gagiannis, Daniel, et al.
Publicado: (2020)

Childhood-onset systemic lupus erythematosus: characteristics and the prospect of glucocorticoid pulse therapy
por: Pan, Lu, et al.
Publicado: (2023)

Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax
por: Yamakawa, Hideaki, et al.
Publicado: (2021)

Glucocorticoids in Sepsis: To Be or Not to Be
por: Vandewalle, Jolien, et al.
Publicado: (2020)

Efficacy and Safety of Tacrolimus in Myasthenia Gravis: A Systematic Review and Meta-analysis
por: Zhang, Zuojie, et al.
Publicado: (2017)

BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept
por: Cai, Shaozhe, et al.
Publicado: (2023)

Comparative effects of hepatocyte growth factor and tacrolimus on acute liver allograft early tolerance
por: Chen, Quanyu, et al.
Publicado: (2023)

Calibration of the Scintillator Hadron Calorimeter of ILD
por: CALICE Collaboration
Publicado: (2009)

Front-end Electronics for the TPC in ILD
por: Hedberg, V, et al.
Publicado: (2015)

Navigational Bronchoscopy with Cryobiopsy for Diagnosis of ILD
por: Figueroa Rodriguez, Fernando, et al.
Publicado: (2022)

Moving from PF-ILD to PPF
por: Bhattacharyya, Parthasarathi
Publicado: (2023)

Genetic factors underlying tacrolimus intolerance after liver transplantation
por: Liu, Yuan, et al.
Publicado: (2022)

Cover ImageReport and Abstracts of the 14th Meeting of IIM, the Interuniversity Institute of Myology, - Assisi (Italy), October 12-15, 2017
por: Gabellini, Davide, et al.
Publicado: (2017)

Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
por: Jee, Adelle S., et al.
Publicado: (2017)

Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases
por: Enomoto, Noriyuki, et al.
Publicado: (2022)

Comparison between mono‐tacrolimus and mono‐glucocorticoid in the treatment of myasthenia gravis
por: Fan, Zhirong, et al.
Publicado: (2023)

The Calcineurin Inhibitor Tacrolimus Specifically Suppresses Human T Follicular Helper Cells
por: Wallin, Elizabeth F., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_97l8c40b36cgn2tcrfercc6jfk